You are currently viewing a new version of our website. To view the old version click .

Pharmaceutics, Volume 16, Issue 6

June 2024 - 149 articles

Cover Story: Despite the high success rates of dental implants, peri-implantitis is currently the most common complication in regard to dental implantology. Prophylaxis and different treatment methods, such as local and systemic antibiotics and antiseptic treatments, have been widely discussed in recent decades, and surgical and nonsurgical techniques present both advantages and disadvantages. However, there is still a need to explore new therapies based on the use of advanced drug delivery systems for the effective treatment of peri-implantitis in the long term and without relapses. Hence, micro- and nano-particles, implants, and injectable hydrogels, among others, should be considered in future peri-implantitis treatments, with the aim being to enhance overall therapy outcomes. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (149)

  • Article
  • Open Access
1,767 Views
13 Pages

The Impact of Chronic Oral Beta-Blocker Intake on Intravenous Bolus Landiolol Response in Hospitalized Intensive Care Patients with Sudden-Onset Supraventricular Tachycardia—A Post Hoc Analysis of a Cross-Sectional Trial

  • Felix Eibensteiner,
  • Emmilie Mosor,
  • Daniel Tihanyi,
  • Sonja Anders,
  • Andrea Kornfehl,
  • Marco Neymayer,
  • Julia Oppenauer,
  • Christoph Veigl,
  • Valentin Al Jalali and
  • Hans Domanovits
  • + 2 authors

Background: Landiolol, a highly cardioselective agent with a short half-life (2.4–4 min), is commonly used as a perfusor or bolus application to treat tachycardic arrhythmia. Some small studies suggest that prior oral β-blocker use results...

  • Article
  • Open Access
4 Citations
2,150 Views
20 Pages

In Vitro and In Vivo Antipsoriatic Efficacy of Protected and Unprotected Sugar–Zinc Phthalocyanine Conjugates

  • Sebastian Makuch,
  • Piotr Kupczyk,
  • Marta Woźniak,
  • Alicja Makarec,
  • Maja Lipińska,
  • Magdalena Klyta,
  • Joanna Sulecka-Zadka,
  • Wiesław Szeja,
  • Mariachiara Gani and
  • Valentina Rapozzi
  • + 2 authors

Psoriasis, a chronic immune-mediated skin disorder affecting over 125 million people globally, is characterized by abnormal keratinocyte proliferation and immune cell infiltration. Photodynamic therapy (PDT) remains underutilized in the treatment of...

  • Article
  • Open Access
10 Citations
3,203 Views
16 Pages

Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate

  • Reyhan Yanikoglu,
  • Canan Yagmur Karakas,
  • Fatih Ciftci,
  • Mert Akın Insel,
  • Zeynep Karavelioglu,
  • Rahmetullah Varol,
  • Abdurrahim Yilmaz,
  • Rabia Cakir,
  • Hüseyin Uvet and
  • Cem Bulent Ustundag

Graphene has become a prominent material in cancer research in recent years. Graphene and its derivatives also attract attention as carriers in drug delivery systems. In this study, we designed a graphene oxide (GO)-based methotrexate (MTX)-loaded an...

  • Article
  • Open Access
2 Citations
2,307 Views
13 Pages

Derivatization of Hyaluronan to Target Neuroblastoma and Neuroglioma Expressing CD44

  • Giau Van Vo,
  • Kummara Madhusudana Rao,
  • Ildoo Chung,
  • Chang-Sik Ha,
  • Seong Soo A. An and
  • Yang H. Yun

Therapeutics for actively targeting over-expressed receptors are of great interest because the majority of diseased tissues originate from normal cells and do not possess a unique receptor from which they can be differentiated. One such receptor is C...

  • Article
  • Open Access
2 Citations
3,169 Views
22 Pages

Background: The lack of reliable biomarkers in response to anti-TNFα biologicals hinders personalized therapy for Crohn’s disease (CD) patients. The motivation behind our study is to shift the paradigm of anti-TNFα biomarker discove...

  • Article
  • Open Access
1,638 Views
13 Pages

Constitutional DNA Polymorphisms Associated with the Plasma Imatinib Concentration in Chronic Myeloid Leukemia Patients

  • Heriberto Bruzzoni-Giovanelli,
  • Habib Zouali,
  • Mourad Sahbatou,
  • Benjamin Maneglier,
  • Jean-Michel Cayuela,
  • Angelita Rebollo,
  • Gustavo H. Marin,
  • Daniela Geromin,
  • Carole Tomczak and
  • Antonio Alberdi
  • + 2 authors

The tyrosine kinase Inhibitor (TKI) imatinib is approved for the treatment of the chronic phase of chronic myeloid leukemia (CP-CML). Pharmacokinetic studies have highlighted the importance of inter-patient variability on imatinib plasma trough conce...

  • Article
  • Open Access
2 Citations
1,774 Views
14 Pages

Personalized SO2 Prodrug for pH-Triggered Gas Enhancement in Anti-Tumor Radio-Immunotherapy

  • Zhiran Chen,
  • Xiaoxiang Zhou,
  • Bo Wu,
  • Han Tang,
  • Wei Wei,
  • Daoming Zhu,
  • Yi Ding and
  • Longyun Chen

The inhibition of the immune response in the tumor microenvironment by therapy regimens can impede the eradication of tumors, potentially resulting in tumor metastasis. As a non-invasive therapeutic method, radiotherapy is utilized for tumor ablation...

  • Article
  • Open Access
1,495 Views
10 Pages

The objective of the present investigation was to evidence the skin retardation phenomenon of lidocaine by gluconic acid as an inactive ingredient involved in citrate-crosslinking chitosan nanoparticles. Lidocaine hydrochloride was loaded in nanopart...

  • Article
  • Open Access
1 Citations
1,873 Views
15 Pages

The high prevalence of acne, which affects nearly 85% of adolescents and young adults, underscores the importance of exploring new therapeutic solutions. The aim of the present study was to design a stable hydrogel formulation containing tetracycline...

of 15

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923Creative Common CC BY license